Curaleaf Holdings (FRA:2XW) WACC %:10.34% (As of Jun. 27, 2026) — 10% Above Median


FRA:2XW Curaleaf Holdings Inc FRA:2XW
46 GF Score
Price €8.23
GF Value €6.56
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Curaleaf Holdings WACC %?

Curaleaf Holdings FRA:2XW +4.25% 46 WACC % is 10.34% as of Jun. 27, 2026, which is 10% above its 10-year median of 9.39. GuruFocus rates FRA:2XW with a GF Score™ of 46/100 and a GF Value™ of €6.56 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,020 Drug Manufacturers companies, Curaleaf Holdings ranks worse than 88.82% on this metric.

As of today (2026-06-27), Curaleaf Holdings's weighted average cost of capital is 10.34%%. Curaleaf Holdings's ROIC % is 0.61% (calculated using TTM income statement data). Curaleaf Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.

*Note: The beta of this company cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.

For a comprehensive WACC calculation, please access the WACC Calculator.


Curaleaf Holdings  (FRA:2XW) WACC % Explanation

Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Curaleaf Holdings's weighted average cost of capital is 10.34%%. Curaleaf Holdings's ROIC % is 0.61% (calculated using TTM income statement data). Curaleaf Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.

*Note: The beta of this company cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.


Be Aware

1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.

2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.

3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.

4. GuruFocus uses the latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.


Related Terms

Curaleaf Holdings WACC % Historical Data

* Premium members only.

The historical data trend for Curaleaf Holdings's WACC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curaleaf Holdings WACC % Chart

Curaleaf Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
WACC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.32 13.26 12.18 11.94 10.69

Curaleaf Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
WACC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.74 10.71 13.89 10.69 10.72

FRA:2XW vs ZTS: WACC % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curaleaf Holdings WACC % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's WACC % distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's WACC % falls into.


FRA:2XW
46GF Score
Curaleaf Holdings Inc FRA:2XW
WACC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curaleaf Holdings WACC % Calculation

The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.

WACC=E/(E + D)*Cost of Equity+D/(E + D)*Cost of Debt*(1 - Tax Rate)

1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, Curaleaf Holdings's market capitalization (E) is €2318.895 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Mar. 2026, Curaleaf Holdings's latest one-year quarterly average Book Value of Debt (D) is €728.4766 Mil.
a) weight of equity = E / (E + D) = 2318.895 / (2318.895 + 728.4766) = 0.7609
b) weight of debt = D / (E + D) = 728.4766 / (2318.895 + 728.4766) = 0.2391

2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 4.376%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. Curaleaf Holdings's beta cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 4.376% + 1 * 6% = 10.376%

3. Cost of Debt:
GuruFocus uses latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.
As of Mar. 2026, Curaleaf Holdings's interest expense (positive number) was €86.912 Mil. Its total Book Value of Debt (D) is €728.4766 Mil.
Cost of Debt = 86.912 / 728.4766 = 11.9307%.

4. Multiply by one minus TTM Tax Rate:
GuruFocus uses the most recent TTM Tax Expense divided by the most recent TTM Pre-Tax Income to calculate the tax rate. The calculated TTM tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated TTM Tax Rate = -10.876 / -76.439 = 14.23%.

Curaleaf Holdings's Weighted Average Cost Of Capital (WACC) for Today is calculated as:

WACC=E / (E + D)*Cost of Equity+D / (E + D)*Cost of Debt*(1 - Tax Rate)
=0.7609*10.376%+0.2391*11.9307%*(1 - 14.23%)
=10.34%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about WACC % →
What does a WACC % of 10.34% mean?
Curaleaf Holdings (FRA:2XW) has a WACC % of 10.34% as of Jun. 27, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Curaleaf Holdings and its competitors. This is 10% above median its historical median of 9.39. According to the industry distribution chart, Curaleaf Holdings ranks #906 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 88.8%.
Is Curaleaf Holdings' WACC % too high?
Curaleaf Holdings' current WACC % of 10.34% is 10% above median its 10-year median of 9.39. The Drug Manufacturers industry median WACC % is 8.90. Curaleaf Holdings' value of 10.34% is 16.2% above this industry median. Based on the distribution chart, Curaleaf Holdings ranks #906 out of 1020 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Curaleaf Holdings has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' WACC % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Curaleaf Holdings ranks #906 out of 1020 companies for WACC %. This places Curaleaf Holdings in the lower half of its industry. The industry median WACC % is 8.90. Curaleaf Holdings' value of 10.34% is 16.2% above this benchmark. While the company's 10-year median is 9.39 vs. the industry median of 8.90, Curaleaf Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Drug Manufacturers company?
The median WACC % among Drug Manufacturers companies is 8.90, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Curaleaf Holdings's current WACC % of 10.34% is 16.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Curaleaf Holdings and its competitors. For the Drug Manufacturers industry, the median WACC % is 8.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curaleaf Holdings's current WACC % is 10.34%, which is 10% above median its own 10-year median of 9.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (FRA:2XW) is currently considered Modestly Overvalued. The stock's GF Value™ is €6.56, compared to a current price of €8.23 — trading 25.4% above its estimated fair value. The current WACC % is 10.34%, which is 10% above median its 10-year median of 9.39 and 16.2% above the Drug Manufacturers industry median of 8.90. Curaleaf Holdings' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For Curaleaf Holdings (FRA:2XW), the current WACC % is 10.34% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Curaleaf Holdings (FRA:2XW) Overvalued in 2026?

Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued. The current stock price of €8.23 is trading 25.4% above its estimated GF Value™ of €6.56. GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.

Key valuation signals for FRA:2XW:

  • WACC %: 10.34% (10% above median its 10-year median of 9.39)
  • GF Value™: €6.56 vs. price of €8.23 (25.4% above fair value)
  • GF Score™: 46/100 with 5 warning signs
  • Industry Position: 16.2% above the Drug Manufacturers median (#906 of 1020)

No single metric tells the full story. See the FRA:2XW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Curaleaf Holdings Business Description

Other Exchanges CURLD:USACURA:Canada
Address 290 Harbor Drive, Stamford, CT, USA, 06902
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
46GF Score

Get the complete analysis for FRA:2XW

WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.23
Price
€6.56
GF Value